|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/115 | |
| A61P 35/00 | |||
| A61K 31/69 | |||
| A61K 31/7088 | |||
| A61K 31/7105 | |||
| A61K 31/713 | |||
| A61K 45/06 |
| (11) | Number of the document | 2613789 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11757776.7 |
| Date of filing the European patent application | 2011-09-09 | |
| (97) | Date of publication of the European application | 2013-07-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/004554 |
| Date | 2011-09-09 |
| (87) | Number | WO 2012/031773 |
| Date | 2012-03-15 |
| (30) | Number | Date | Country code |
| 10009397 | 2010-09-09 | EP |
| (72) |
PURSCHKE, Werner, DE
JAROSCH, Florian, DE
EULBERG, Dirk, DE
KLUSSMANN, Sven, DE
BUCHNER, Klaus, DE
MAASCH, Christian, DE
DINSE, Nicole, DE
ZBORALSKI, Dirk, DE
|
| (73) |
Noxxon Pharma AG,
Max-Dohrn-Strasse 8-10, 10589 Berlin,
DE
|
| (54) | SDF-1 BINDING NUCLEIC ACIDS AND THE USE THEREOF IN CANCER TREATMENT |
| SDF-1 BINDING NUCLEIC ACIDS AND THE USE THEREOF IN CANCER TREATMENT |